4 free views remaining today

Langerhans-cell histiocytosis

ICD-10 Codes

Related ICD-10:

Description

What is Langerhans Cell Histiocytosis (LCH)?

Langerhans cell histiocytosis (LCH) is a rare and complex condition that affects the body's immune system. It is characterized by an abnormal proliferation of Langerhans cells, a type of white blood cell found in healthy individuals.

Key Features:

  • Immune System Disorder: LCH is a disorder of the immune system, where excess Langerhans cells accumulate in various parts of the body.
  • Rare Condition: LCH is a rare condition that affects mostly children, but can also occur in adults of all ages.
  • Variable Symptoms: The symptoms of LCH can vary widely, ranging from isolated bone lesions to multisystem disease.

Common Affected Areas:

  • Bones: 80% of cases involve the skeleton, with pain and swelling being common symptoms.
  • Skin: 33% of cases affect the skin, causing persistent rashes or cradle cap-like conditions.
  • Pituitary Gland: 25% of cases involve the pituitary gland, which can lead to hormonal imbalances.

Causes and Risk Factors:

  • Genetic Mutations: LCH is often associated with genetic mutations in the MAPKinase pathway (MAPK).
  • Unknown Causes: The exact causes of LCH are still unknown, but research suggests that it may be related to an abnormal proliferation of Langerhans cells.

References:

  • [2] Description. Langerhans cell histiocytosis is a disorder in which excess immune system cells called Langerhans cells build up in the body.
  • [5] Nov 2, 2022 — Langerhans cell histiocytosis (LCH) is a group of idiopathic disorders characterized by the presence of cells with characteristics similar to bone marrow–
  • [15] Langerhans cell histiocytosis (LCH) is a heterogeneous disease, characterized by accumulation of dendritic cells with features similar to epidermal Langerhans cells in various organs.

Additional Characteristics

  • A rare and complex condition that affects the body's immune system.
  • A disorder of the immune system, where excess Langerhans cells accumulate in various parts of the body.
  • A heterogeneous disease, characterized by accumulation of dendritic cells with features similar to epidermal Langerhans cells in various organs.

Signs and Symptoms

Symptoms of Langerhans Cell Histiocytosis (LCH) can vary greatly from person to person, depending on which part of the body is affected.

  • Mild symptoms: Some people may experience mild symptoms such as increased thirst or dehydration, increased need to urinate (pee), feeling tired, rapid weight change (either up or down), and general discomfort, uneasiness, or ill feeling [7][8].
  • Bone pain and swelling: LCH can cause bone pain and swelling, which can lead to fractures in the arms or legs [9][10].
  • Rash and skin symptoms: A scaly seborrheic, eczematoid, sometimes purpuric rash involving the scalp, ear canals, abdomen, and intertriginous areas of the neck and face is a common symptom in severe cases [4].
  • Respiratory symptoms: Lung infiltrates and shortness of breath are also possible symptoms [15].
  • Systemic symptoms: In more severe cases, LCH can cause systemic symptoms such as fever, general discomfort, uneasiness, or ill feeling, and increased amount of urine [8].

It's essential to note that some people may experience no symptoms at all, especially in the early stages of the disease.

  • Failure to gain height and weight: In children, the most common symptoms are failure to gain height and weight, which can be a sign of multisystem disease [14].
  • Bone lesions and swelling: Swelling or a lump over a bone, such as the skull, jawbone, ribs, pelvis, spine, arms, or legs, is another possible symptom [9][10].

Symptoms can range from mild to severe and may vary depending on the type of LCH.

  • Isolated bone lesions: Some people may experience isolated bone lesions with no other symptoms.
  • Multisystem disease: In more severe cases, LCH can cause multisystem disease, which affects multiple parts of the body.

Early diagnosis and treatment are crucial to manage the symptoms and prevent complications.

References:

[1] Not applicable

[4] Jun 6, 2024 — Signs or symptoms of LCH that affects the bone may include: Swelling or a lump over a bone, such as the skull, jawbone, ribs, pelvis, spine, ...

[7] Jun 6, 2024 — Signs or symptoms of LCH that affects the bone may include: Swelling or a lump over a bone, such as the skull, jawbone, ribs, pelvis, spine, ...

[8] Symptoms · Bone pain · Chest pain · Cough · Fever · General discomfort, uneasiness, or ill feeling · Increased amount of urine · Rash · Shortness of breath ...

[9] Jun 6, 2024 — Signs or symptoms of LCH that affects the bone may include: Swelling or a lump over a bone, such as the skull, jawbone, ribs, pelvis, spine, ...

[10] That can cause pain and swelling, and sometimes it can fracture your arms or legs. LCH symptoms can range from mild to more serious.

[14] Langerhan's Cell Histiocytosis (LCH) is a rare disorder that occurs in about one in 200,000 children and adults each year. The disease causes an abnormally high level of histiocyte cells, which are produced in bone marrow. ... Signs & symptoms. Among children, the most common symptoms of histiocytosis are: Failure to gain height and weight ...

[15] Langerhans cell histiocytosis (LCH) is a proliferation of dendritic mononuclear cells with infiltration into organs locally or diffusely. Most cases occur in children. Manifestations may include lung infiltrates; bone lesions; rashes; and hepatic, hematopoietic, and endocrine dysfunction.

Additional Symptoms

  • Respiratory symptoms
  • Systemic symptoms
  • Feeling tired
  • Bone pain and swelling
  • Increased thirst or dehydration
  • Increased need to urinate (pee)
  • Rapid weight change
  • Multisystem disease
  • General discomfort, uneasiness, or ill feeling
  • Rash and skin symptoms
  • Failure to gain height and weight
  • Bone lesions and swelling
  • Isolated bone lesions

Diagnostic Tests

Diagnostic Tests for Langerhans Cell Histiocytosis

Langerhans cell histiocytosis (LCH) is a rare disorder that requires a comprehensive diagnostic approach to confirm the diagnosis. The following tests are commonly used to diagnose and monitor LCH:

  • Biopsy: A biopsy of the affected area is often necessary to confirm the diagnosis of LCH. This involves removing a small sample of tissue, which is then examined by a pathologist for the presence of Langerhans cells.
  • Blood Tests: Blood tests may be performed to evaluate the levels of certain enzymes and proteins in the blood, such as alkaline phosphatase and gamma-glutamyl transferase. These tests can help identify any organ dysfunction or damage caused by LCH.
  • Imaging Studies: Imaging studies, such as X-rays, CT scans, and MRI scans, may be used to evaluate the extent of disease involvement in various organs, including the bones, lungs, liver, and spleen.
  • Bone Marrow Biopsy: A bone marrow biopsy may be performed to evaluate the presence of Langerhans cells in the bone marrow.
  • Genetic Testing: Genetic testing may be performed to identify any genetic mutations associated with LCH.

Specific Diagnostic Tests

The following specific diagnostic tests are mentioned in the search results:

  • Skin Biopsy: A skin biopsy is a procedure where a small sample of skin tissue is removed and examined by a pathologist for the presence of Langerhans cells.
  • Blood Count (CBC): A CBC test checks the levels of red blood cells, white blood cells, and clotting cells in the blood.
  • Urine Osmolality Test: This test measures the concentration of urine to evaluate kidney function.
  • Radiography: Radiography is a diagnostic imaging technique that uses X-rays to produce images of internal structures.

References

  1. [5] A skin biopsy is performed to remove a small section of the affected area and examine it for Langerhans cells.
  2. [10] Blood tests may be performed to evaluate organ function and identify any damage caused by LCH.
  3. [12] Imaging studies, such as X-rays and CT scans, are used to evaluate disease involvement in various organs.

Note: The references provided are based on the search results and may not be an exhaustive list of all relevant diagnostic tests for Langerhans cell histiocytosis.

Treatment

Treatment Options for Langerhans Cell Histiocytosis

Langerhans cell histiocytosis (LCH) is a rare disorder that can be treated with various medications, depending on the severity and location of the disease. The goal of treatment is to reduce the number of abnormal cells and alleviate symptoms.

Chemotherapy

Chemotherapy uses strong drugs to kill or slow down the growth of cancer cells. In LCH, chemotherapy may be used to treat widespread disease or when other treatments have failed. Common chemotherapy drugs for LCH include:

  • Vinblastine: often combined with prednisone
  • 6-mercaptopurine: taken orally
  • Methotrexate: a low-to-moderate dose is typically used

Corticosteroids

Corticosteroids, such as prednisone, are commonly used to reduce inflammation and swelling. They may be given alone or in combination with other medications.

Targeted Therapy

Targeted therapy uses drugs or substances that specifically target the abnormal cells causing LCH. This type of treatment is still being researched and developed for LCH.

  • BRAF inhibitors: block proteins needed for cell growth
  • Monoclonal antibodies: identify and attack specific cancer cells

Other Medications

In addition to chemotherapy, corticosteroids, and targeted therapy, other medications may be used to treat LCH. These include:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation
  • Antineoplastic agents to kill or slow down the growth of cancer cells
  • Phototherapy agents to help manage symptoms

References

  1. [4] Chemotherapy uses strong drugs to kill cells, or stop or slow their growth.
  2. [5] The combination of cytotoxic drugs and systemic steroids is generally effective.
  3. [6] Langerhans Cell Histiocytosis (LCH) treatment depends on where it is found in the body and whether the LCH is low or high risk.
  4. [9] Types of targeted therapy include BRAF inhibitors, which block proteins needed for cell growth and may kill cancer cells, and monoclonal antibodies, which are ...
  5. [11] Langerhans Cell Histiocytosis (LCH) treatment can include chemotherapy, surgery, radiation therapy, photodynamic therapy, immunotherapy, and targeted therapy.

Note: The effectiveness of these treatments may vary depending on individual circumstances and the severity of the disease. It is essential to consult with a healthcare professional for personalized advice and guidance.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Langerhans cell histiocytosis (LCH) is a rare disorder characterized by the accumulation of abnormal cells called Langerhans cells in various organs, including bones, skin, and other tissues. When diagnosing LCH, it's essential to consider differential diagnoses that can mimic its symptoms.

Differential Diagnoses:

  • Osteomyelitis: A bacterial or fungal infection of the bone, which can cause similar symptoms such as bone pain, swelling, and fever [8].
  • Round Blue Cell Tumors: A group of aggressive tumors that can affect bones and soft tissues, including Ewing's sarcoma and lymphoma [9].
  • Metastases: Cancer cells from other parts of the body can spread to bones, causing similar symptoms such as bone pain and swelling [8].
  • Primary Bone Cancers: Such as osteosarcoma and chondrosarcoma, which can cause bone pain, swelling, and other symptoms similar to LCH [9].
  • Seborrheic Dermatitis: A skin condition that can cause redness, itching,

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_9835
owl#annotatedSource
t418460
oboInOwl#hasOBONamespace
disease_ontology
rdf-schema#comment
OMIM mapping confirmed by DO. [SN].
oboInOwl#hasAlternativeId
DOID:9582
oboInOwl#id
DOID:2571
core#notation
DOID:2571
oboInOwl#hasDbXref
UMLS_CUI:C0023381
IAO_0000115
A histiocytosis that is characterized by clonal proliferation of Langerhans cells.
oboInOwl#hasExactSynonym
Letterer-Siwe disease of spleen
rdf-schema#label
Langerhans-cell histiocytosis
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
t418359
RO_0002200
http://purl.obolibrary.org/obo/HP_0006530
relatedICD
http://example.org/icd10/C96.6
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.